MedPath

Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation

Not Applicable
Completed
Conditions
Pediatric ALL
Anemia
Healthy
Interventions
Device: Rad-67 Pulse oximeter
Registration Number
NCT02930850
Lead Sponsor
Masimo Corporation
Brief Summary

The purpose study is to report on the accuracy of noninvasive hemoglobin (SpHb) as compared to hemoglobin measurements obtained from a laboratory hematology analyzer.

Detailed Description

The primary objective of this clinical investigation is to report on the accuracy of the Rad-67 and DCI Mini sensor to measure SpHb as compared to hemoglobin measurements obtained from a manual HiCN analytical method and automated Beckman Coulter laboratory hematology analyzers.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
447
Inclusion Criteria
  • Age: Greater than one month
  • Weight: Greater than or equal to 3kg
  • The subject or the subject's legally authorized representative has given written informed consent/assent to participate in the study
Exclusion Criteria
  • Subjects with skin abnormalities at the planned application sites that may interfere with sensor application, per directions-for-use (DFU) or trans-illumination of the site, such as burns, scar tissue, nail polish, acrylic nails, infections, abnormalities, etc.
  • Subjects deemed not suitable for the study at the discretion of the investigator
  • Subjects unlikely to be able to refrain from excessive motion during data collection. Excessive motion includes postural changes, making hand gestures, involuntary muscular movements, etc.
  • Decision-impaired adult and pediatric subjects who are unable to give consent and assent

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Test subjectsRad-67 Pulse oximeterAll subjects are enrolled and receive Rad-67 Pulse oximeter sensor for measurement of hemoglobin.
Primary Outcome Measures
NameTimeMethod
Accuracy of hemoglobin measurementUp to 2 hours per subject

Accuracy willl be determined by comparing the noninvasive hemoglobin measurement of the pulse oximeter to the hemoglobin value obtained from a blood sample and calculating the arithmetic root mean square(Arms) error value.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (7)

Site 2

🇺🇸

Irvine, California, United States

Site 6

🇺🇸

Torrance, California, United States

Site 4

🇺🇸

Burbank, California, United States

Site 5

🇺🇸

Burbank, California, United States

Site 7

🇺🇸

Lake Forest, California, United States

Site 3

🇺🇸

National City, California, United States

Site 1

🇺🇸

Charlotte, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath